Evaluation of markers of deep vein thrombosis in patients undergoing surgery for maxillofacial malignancies

Journal of Cranio-Maxillo-Facial Surgery

Volumn 27, Issue 4, 1999, Pages 266-270

  Wendel, H P ^a   Scholpp, J ^a   Schulze, H J ^a   Heller, W ^a   Schwenzer, N ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; MARKER; NADROPARIN; THROMBIN;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; HIGH RISK PATIENT; HUMAN; KALLIKREIN KININ SYSTEM; LUNG EMBOLISM; MALIGNANT NEOPLASTIC DISEASE; MAXILLOFACIAL SURGERY; PROPHYLAXIS; THROMBOEMBOLISM;

EID: 0032748386     PISSN: 03010503     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-5182(99)80039-0     Document Type: Article

References (28)

1. Boneu B Bes G Pelzer H Sie P Boccalon H D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis Thromb Haemost 65 1991 28
2. Borrel MTE The post-mortem incidence of pulmonary embolism in a hospital population Br J Surg 55 1986 347
3. Brennhovd IO Heparin in der Thrombose-Embolie-Behandlung Nord Med 37 1956 9
4. Colman RW Schmaier AH Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes Blood 90 1997 3819
5. Delvos U Gajdusek C Sage H Harker LA Schwartz SM Interactions of vascular wall cells with collagen gels Lab Invest 46 1982 61
6. Delvos U Müller-Berghaus G Die Regulation der Blutgerinnung Naturwissenschaften 72 1985 461
7. Dvorak HF Thrombosis and cancer Hum Pathol 18 1987 275
8. Egberg N Gallimore MJ Jacobsson J Effects of plasma kallikrein infusions into pigs on haemodynamic and haemostatic variables Fibrinolysis 2 1988 95
9. Faivrc R Neuhart E Mirshahi M Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin Semin Thromb Hemost 15 1989 435
10. Francis JL Biggerstaff J Amirkhosravi A Hemostasis and malignancy Semin Thromb Hemost 24 1998 93
11. Fuhrer G Gallimore MJ Heller W Hoffmeister HE F XII (Review) Blut 61 1990 258
12. Gallimore MJ Amundsen E Larsbraaten M Lyngaas K Fareid E Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays Thromb Res 16 1979 695
13. Gallimore MJ Friberger P Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein ‘like’ activity in human plasma Thromb Res 25 1982 293
14. Gallimore MJ Chromogenic peptide substrate assays for determining components of the plasma kallikrein system Scand J Clin Lab Invest 45 1985 127
15. Hoek JA Nurmohamed MT ten Cate JW Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement Thromb Haemost 62 1989 1050
16. Holvoet P Cleemput H Collen D Assay of human tissue-type plasmonogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA Thromb Haemost 54 1985 684
17. Kakkar VV Murray WJ Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a co-operative study Br J Surg 72 1985 786
18. Koppenhagen K Matthes M Heparin-dihydergot or heparin alone in thrombosis prophylaxis? Med Welt 33 1982 216
19. Kwaan HC The biologic role of components of the plasminogen-plasmin system Progress Cardiovascular Diseases 34 1992 309
20. Mammen EF Contact activation: the interaction of clotting, fibrinolytic, kinin and complement systems Biomedical Progress 2 1990 31
21. Marshall M Bedeutung tiefer Beinvenenthrombosen im chirurgischen Krankengut Med Klin 81 1986 11
22. Müller-Berghaus G Physiologie und Regulation der Blutgerinnung und Fibrinolyse Med Welt 38 1987 407
23. Paques EP Heimburger N Das fibrinolytische System Haemostaseologie 6 1986 139
24. Peuten M Kieferchirurgische Eingriffe bei Antikoagulanzienbehandlung Hämostaseologie 9 1989 262
25. Pezzuoli G Neri Serneri GG Settembrini PG Effectiveness and safety of the low-molecular-weight heparin CY 216 in the prevention of fatal pulmonary embolism and thromboembolic death in general surgery A multicentre, double-blind, randomized, controlled clinical trial versus placebo (STEP) Haemostasis 20 1990 STEP Study Group 193 Suppl 1
26. Preissner KT Müller-Berghaus G Molekulare Wechselwirkungen zwischen Komplement-, Gerinnungs- und Fibrinolysesystem Haemostaseologie 6 1986 67
27. Ratnoff OD Calopy JE A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction from plasma J Clin Invest 34 1955 602
28. Trousseau A Phlegmasia alba dolens. Clinique medicale de l'hoteldieu de Paris 1865 The New Sydenham Society London 94 96